314 related articles for article (PubMed ID: 28556385)
21. Propranolol in the treatment of problematic infantile hemangioma: review of 35 consecutive patients from a vascular anomalies clinic.
Bertrand J; Sammour R; McCuaig C; Dubois J; Hatami A; Ondrejchak S; Boutin C; Bortoluzzi P; Laberge LC; Powell J
J Cutan Med Surg; 2012; 16(5):317-23. PubMed ID: 22971306
[TBL] [Abstract][Full Text] [Related]
22. Oral Propranolol for the Treatment of Infantile Hemangiomas in the Post-Proliferative Phase: A-Single Center Retrospective Study of 31 Cases.
Tian Y; Xu DP; Tong S; Xi SL; Liu ZM; Wang XK
J Oral Maxillofac Surg; 2016 Aug; 74(8):1623-9. PubMed ID: 27055227
[TBL] [Abstract][Full Text] [Related]
23. Intolerable side effects during propranolol therapy for infantile hemangioma: frequency, risk factors and management.
Ji Y; Chen S; Wang Q; Xiang B; Xu Z; Zhong L; Yang K; Lu G; Qiu L
Sci Rep; 2018 Mar; 8(1):4264. PubMed ID: 29523832
[TBL] [Abstract][Full Text] [Related]
24. Aesthetic Outcome of Propranolol vs Atenolol Treatment of Children with Infantile Haemangioma.
Hermans MM; Breugem CC; Schappin R; Jonge Poerink E; Mendels EJ; Ragamin A; Breur JMPJ; Langeveld HR; Raphael MF; De Laat PCJ; De Wildt SN; Rietman AB; Pasmans SGMA; De Graaf M
Acta Derm Venereol; 2022 Oct; 102():adv00788. PubMed ID: 35506358
[TBL] [Abstract][Full Text] [Related]
25. Adverse effects of propranolol when used in the treatment of hemangiomas: a case series of 28 infants.
de Graaf M; Breur JMPJ; Raphaël MF; Vos M; Breugem CC; Pasmans SGMA
J Am Acad Dermatol; 2011 Aug; 65(2):320-327. PubMed ID: 21601311
[TBL] [Abstract][Full Text] [Related]
26. Propranolol treatment for severe infantile hemangiomas: a single-centre 3-year experience.
Georgountzou A; Karavitakis E; Klimentopoulou A; Xaidara A; Kakourou T
Acta Paediatr; 2012 Oct; 101(10):e469-74. PubMed ID: 22804809
[TBL] [Abstract][Full Text] [Related]
27. Study of Cognitive Function in Children Treated with Propranolol for Infantile Hemangioma.
González-Llorente N; Del Olmo-Benito I; Muñoz-Ollero N; Descalzo MA; García-Doval I; Torrelo A
Pediatr Dermatol; 2017 Sep; 34(5):554-558. PubMed ID: 28804922
[TBL] [Abstract][Full Text] [Related]
28. Propranolol for infantile hemangiomas.
Bagazgoitia L; Torrelo A; Gutiérrez JC; Hernández-Martín A; Luna P; Gutiérrez M; Baño A; Tamariz A; Larralde M; Alvarez R; Pardo N; Baselga E
Pediatr Dermatol; 2011; 28(2):108-14. PubMed ID: 21385205
[TBL] [Abstract][Full Text] [Related]
29. Cardiovascular and blood glucose parameters in infants during propranolol initiation for treatment of symptomatic infantile hemangiomas.
Puttgen KB; Summerer B; Schneider J; Cohen BA; Boss EF; Bauman NM
Ann Otol Rhinol Laryngol; 2013 Sep; 122(9):550-4. PubMed ID: 24224397
[TBL] [Abstract][Full Text] [Related]
30. A survey on the application of oral propranolol and atenolol for the management of infantile hemangiomas in mainland China: Survey on propranolol atenolol hemangiomas.
Zhao ZL; Liu C; Wang QZ; Zhang WB; Shao L; Wu HW; Zheng JW
Medicine (Baltimore); 2021 Jan; 100(1):e24146. PubMed ID: 33429792
[TBL] [Abstract][Full Text] [Related]
31. Propranolol for infantile hemangiomas: early experience at a tertiary vascular anomalies center.
Buckmiller LM; Munson PD; Dyamenahalli U; Dai Y; Richter GT
Laryngoscope; 2010 Apr; 120(4):676-81. PubMed ID: 20112413
[TBL] [Abstract][Full Text] [Related]
32. Treatment for Infantile Hemangiomas: Selection Criteria, Safety, and Outcomes Using Oral Propranolol During the Early Phase of Propranolol Use for Hemangiomas.
MacIsaac ZM; Nayar HS; Gehris R; Mehta D; Geisler S; Grunwaldt LJ
J Craniofac Surg; 2016 Jan; 27(1):159-62. PubMed ID: 26674892
[TBL] [Abstract][Full Text] [Related]
33. Atenolol as an alternative to propranolol for the management of sleep disturbances in the treatment of infantile hemangiomas.
Gumina ME; Yan AC
Pediatr Dermatol; 2019 Jul; 36(4):556-557. PubMed ID: 30983047
[TBL] [Abstract][Full Text] [Related]
34. Propranolol induced hypoglycemia.
Horev A; Haim A; Zvulunov A
Pediatr Endocrinol Rev; 2015 Mar; 12(3):308-10. PubMed ID: 25962208
[TBL] [Abstract][Full Text] [Related]
35. Ultrasound in assessing the efficacy of propranolol therapy for infantile hemangiomas.
Shi H; Song H; Wang J; Xia L; Yang J; Shang Y; Zhou H
Ultrasound Med Biol; 2014 Nov; 40(11):2622-9. PubMed ID: 25220276
[TBL] [Abstract][Full Text] [Related]
36. Oral atenolol therapy for proliferating infantile hemangioma: A prospective study.
Ji Y; Wang Q; Chen S; Xiang B; Xu Z; Li Y; Zhong L; Jiang X; Yang X
Medicine (Baltimore); 2016 Jun; 95(24):e3908. PubMed ID: 27310994
[TBL] [Abstract][Full Text] [Related]
37. Adverse effects of propranolol treatment for infantile hemangiomas in China.
Jian D; Chen X; Babajee K; Su J; Li J; Hu X; Xie H; Li J
J Dermatolog Treat; 2014 Oct; 25(5):388-90. PubMed ID: 23216314
[TBL] [Abstract][Full Text] [Related]
38. Propranolol as the first-line therapy for infantile hemangiomas: preliminary results of two centers.
Celik A; Tiryaki S; Musayev A; Kismali E; Levent E; Ergun O
J Drugs Dermatol; 2012 Jul; 11(7):808-11. PubMed ID: 22777220
[TBL] [Abstract][Full Text] [Related]
39. A further experience of propranolol for severe infantile hemangiomas of the face: an observational study.
Greco A; D'Erme AM; Zamma Gallarati B; Caputo R; de Martino M
Dermatol Ther; 2014; 27(4):198-202. PubMed ID: 24548454
[TBL] [Abstract][Full Text] [Related]
40. Preliminary experience on treatment of infantile hemangioma with low-dose propranolol in China.
Ma X; Zhao T; Xiao Y; Yu J; Chen H; Huang Y; Liu J; Lin J; Ouyang T
Eur J Pediatr; 2013 May; 172(5):653-9. PubMed ID: 23340697
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
